Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

卷:1842

Article

Wronkowitz, Nina¹  Goergens, Sven W.¹  Romacho, Tania¹  Villalobos, Laura A.²  Sanchez-Ferrer, Carlos F.²  Peiro, Concepcion²  Sell, Henrike¹  Eckel, Juergen¹ 

[1] German Diabet Ctr, Paul Langerhans Grp Integrat Physiol, D-40225 Dusseldorf, Germany

[2] Univ Autonoma Madrid, Sch Med, Dept Pharmacol & Therapeut, E-28049 Madrid, Spain

关键词: DPP4;    Smooth muscle cells;    Proliferation;    Inflammation;    Adipokines;    Atherosclerosis;   

DOI  :  10.1016/j.bbadis.2014.06.004

来源: Elsevier

【 摘 要 】

DPP4 is an ubiquitously expressed cell-surface protease that is shedded to the circulation as soluble DPP4 (sDPP4). We recently identified sDPP4 as a novel adipokine potentially linking obesity to the metabolic syndrome. The aim of this study was to investigate direct effects of sDPP4 on human vascular smooth muscle cells (hVSMCs) and to identify responsible signaling pathways. Using physiological concentrations of sDPP4, we could observe a concentration-dependent activation of ERK1/2 (3-fold) after 6 h, which remained stable for up to 24 h. Additionally, 5DPP4 treatment induced a 1.5-fold phosphorylation of the NF-kappa B subunit p65. In accordance with sDPP4-induced stress and inflammatory signaling, sDPP4 also stimulates hVSMC proliferation. Furthermore we could observe an increased expression and secretion of pro-inflammatory cytokines like interleukin (IL)-6, IL-8 and MCP-1 (2.5-, 2.4- and 1.5-fold, respectively) by the 5DPP4 treatment. All direct effects of sDPP4 on signaling, proliferation and inflammation could completely be prevented by DPP4 inhibition. Bioinformatic analysis and signaling signature induced by sDPP4 suggest that 5DPP4 might be an agonist for PAR2. After the silencing of PAR2, the sDPP4-induced ERK activation as well as the proliferation was totally abolished. Additionally, the sDPP4-induced upregulation of IL-6 and IL-8 could completely be prevented by the PAR2 silencing. In conclusion, we show for the first time that 5DPP4 directly activates the MAPK and NF-kappa B signaling cascade involving PAR2 and resulting in the induction of inflammation and proliferation of hVSMC Thus, our in vitro data might extend the current view of sDPP4 action and shed light on cardiovascular effects of DPP4-inhibitors. (C) 2014 Elsevier B.V. All rights reserved.

【 授权许可】

Free